AI Stock Monitor
IBM - IBM
IBM is a North America covered company in The Hedge Book research universe.
Public company · North America · Information Technology · IT Consulting & Other Services · Infrastructure Software · Dow constituent
0 followers · Follow to include this stock in your daily 9:30 AM Central watchlist email.
NYSE · Information Technology · Research updated · Market data updated Research and source refreshes run four times daily. The timestamps above identify the latest successful research and market-data updates.
Hedge Score
50
/100
Price History
IBM chart
AI-Assisted Chart Analysis
IBM technical analysis
Calculated from verified chart history for the selected tenor; no news or fundamental assumptions are used.
Mixed trend: the latest level is below its 20-period average, without full long-term confirmation.
RSI is 48, a neutral reading. Above 70 can signal extension; below 30 can signal exhaustion.
The first technical watch zone is 229.55. A break below 205.77 invalidates the near-term support setup.
The first resistance/watch zone is 249.09. A confirmed break above 306.13 supports continuation.
Annualized realized volatility is +62.4%. Maximum lookback drawdown is -32.8%, from a high-water mark of 306.13 to 205.77.
Potential levels are conditional chart scenarios, not personalized advice or instructions to buy or sell.
How To Read This Stock Brief
Higher means the current research setup is stronger across signal, confidence, catalysts, risk balance, and market context. Lower means the setup is weaker or less supported.
Higher confidence means the evidence is more consistent and relevant. It does not mean the stock has that percentage chance of going up.
Bullish, Bearish, or Neutral is the current AI research stance. It is designed to help you ask better questions, not to replace your decision process.
This shows how signed-in users are voting. It is useful sentiment context, not proof that the crowd is right.
What Changed Today
- Yahoo Finance delayed market data reported IBM at 231.93 USD; the latest daily move rose +1.04%. This is a verified market-price signal only and does not by itself confirm a change in company fundamentals.
Why It Matters
- The verified +1.04% daily move is current market context for IBM.
- It can affect near-term sentiment, but price action alone does not establish a change in earnings, asset quality, competitive position, valuation, catalysts, or risks.
- Those require a separately sourced filing or company update.
AI Opinion
- Read: The current evidence-grounded AI read is bullish.
- Evidence: While the $1 billion federal award provides a strong endorsement of IBM's technological leadership, the market's recent negative price action indicates that investors are prioritizing near-term margin and growth metrics over long-term R&D potential.
- Uncertainty: The company's ability to successfully integrate AI into its consulting services will be the primary determinant of whether it can re-accelerate software revenue growth.
- Watch: We remain cautious until there is clearer evidence that the software growth slowdown is transitory rather than structural, as this segment is vital for maintaining the company's premium valuation.
Key Risks
- Persistent deceleration in software revenue growth could undermine the thesis that IBM is successfully transitioning to a high-growth AI and cloud-centric model.
- Increased capital intensity required to support large-scale quantum and AI infrastructure projects may compress free cash flow, potentially limiting the company's ability to maintain its dividend growth trajectory.
- Regulatory or political shifts regarding federal funding for technology initiatives could jeopardize the expected benefits of the $1 billion quantum award, creating uncertainty around project funding.
- Competitive pressure from agile, AI-native firms and other legacy tech giants could erode IBM's market share in the IT consulting and enterprise software space.
Upcoming Catalysts
- Future earnings reports providing granular detail on the profitability and revenue contribution of AI-integrated consulting services will be critical for re-rating the stock.
- Updates on the deployment and commercialization milestones of the $1 billion quantum project will serve as a key indicator of the company's ability to monetize its R&D investments.
- Any official guidance or management commentary addressing the recent software growth slowdown will be essential to confirm whether the trend is cyclical or structural.
- Continued dividend announcements or share repurchase updates will act as a baseline support for the stock, provided that cash flow generation remains robust.
Upcoming Events
No verified update available
Last Updated
Sources and verification
Each generated research claim remains linked to its supporting update. Primary evidence comes from filings, company materials, or regulators; secondary evidence provides additional context.
- Published stock briefSecondary sourceReportedCan Accenture Stock Keep Rising On Growth It Has To Buy? · Published 2026-09-22 00:06:02Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedIBM Drops as $2 Billion Builds a Quantum Manufacturing Platform - Yahoo Finance · Published 2026-09-22 00:06:02Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedIBM Drops as $2 Billion Builds a Quantum Manufacturing Platform · Published 2026-09-22 00:06:02Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedWarren Buffett's $35 Billion Bet on Tim Cook's Apple Grew to $185 Billion Pretax. Here's What That Stake Says About Long-Term Investing. · Published 2026-09-22 00:06:02Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedCould You Have Seen Accenture Stock's Rebound Coming? · Published 2026-09-22 00:06:02Open verification sourceSupports: Published stock brief
Market-data attributionYahoo Finance delayed market data · provider detailsMarket prices are supporting signals only and do not establish the research conclusion.
Community View
Sign in with Google to vote once per stock.
Total votes: 0
Disclaimer
The Hedge Book provides AI-assisted educational market research. It is not a registered investment adviser, broker, dealer, or financial planner. Content may contain errors and should be independently verified. Do not treat this page as personalized advice to buy, sell, or hold any security.